Stock listing
BOATS:ERNA Ernexa Therapeutics Inc. Stock
US listing (BOATS) of Ernexa Therapeutics Inc. · home listing NASDAQ:ERNA
Follow Ernexa Therapeutics Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ERNA
$1.97 USD -0.14 (-6.6%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ERNA
- Day range
- $1.95 – $2.14 USDOct 30, 2026
- Volume
- 4,493 sharesOct 30, 2026
- Market cap
- $3.22M USDAt the close on Oct 30, 2026 · price × 1.63M shares outstanding
- 52-week range
- $1.84 – $48.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $172,076 USDMedian day 25,900 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ERNA · Home | $1.97 USD | -0.14 (-6.6%) | 4,493 | $2.08 | $2.14 | $1.95 | $2.11 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ERNA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.97 | -0.14 | -6.6% | $2.08 | $2.14 | $1.95 | 4,493 | |
| $2.11 | +0.13 | +6.6% | $2.03 | $2.11 | $1.998 | 7,265 | |
| $1.98 | -0.013 | -0.7% | $1.91 | $2.03 | $1.91 | 3,471 | |
| $1.993 | +0.055 | +2.8% | $2.12 | $2.12 | $1.96 | 7,436 | |
| $1.938 | -0.127 | -6.2% | $1.98 | $2.08 | $1.92 | 11,182 | |
| $2.065 | -0.01 | -0.5% | $2.075 | $2.09 | $2.03 | 5,931 | |
| $2.075 | -0.035 | -1.7% | $2.095 | $2.125 | $1.98 | 16,467 | |
| $2.11 | -0.13 | -5.8% | $2.19 | $2.255 | $2.08 | 9,569 | |
| $2.24 | +0.26 | +13.1% | $1.96 | $2.26 | $1.89 | 48,186 | |
| $1.98 | -0.11 | -5.3% | $2.04 | $2.07 | $1.839 | 44,353 | |
| $2.09 | -0.08 | -3.7% | $2.17 | $2.23 | $2.04 | 24,617 | |
| $2.17 | +0.06 | +2.8% | $2.10 | $2.23 | $2.05 | 7,004 | |
| $2.11 | -0.10 | -4.5% | $2.20 | $2.20 | $2.013 | 10,300 | |
| $2.21 | 0.00 | 0.0% | $2.19 | $2.24 | $2.18 | 8,312 | |
| $2.21 | -0.19 | -7.9% | $2.40 | $2.40 | $2.125 | 30,705 | |
| $2.40 | -0.09 | -3.6% | $2.45 | $2.49 | $2.25 | 46,599 | |
| $2.49 | +0.10 | +4.2% | $2.40 | $2.70 | $2.12 | 214,740 | |
| $2.39 | +0.155 | +6.9% | $2.25 | $2.39 | $2.15 | 662,923 | |
| $2.235 | -0.465 | -17.2% | $2.75 | $2.96 | $2.20 | 91,550 | |
| $2.70 | -0.26 | -8.8% | $3.04 | $3.058 | $2.70 | 21,552 | |
| $2.96 | 0.00 | 0.0% | $3.00 | $3.28 | $2.90 | 40,810 | |
| $2.96 | -0.24 | -7.5% | $3.13 | $3.236 | $2.84 | 35,741 | |
| $3.20 | +0.04 | +1.3% | $3.24 | $3.47 | $3.16 | 42,635 | |
| $3.16 | -0.31 | -8.9% | $3.738 | $3.738 | $3.044 | 61,865 | |
| $3.47 | +0.025 | +0.7% | $3.46 | $3.50 | $3.20 | 25,791 | |
| $3.445 | -0.175 | -4.8% | $3.73 | $3.848 | $3.40 | 21,417 | |
| $3.62 | -0.03 | -0.8% | $3.785 | $3.821 | $3.61 | 11,526 | |
| $3.65 | -0.15 | -3.9% | $3.73 | $3.79 | $3.65 | 6,237 | |
| $3.80 | -0.16 | -4.0% | $3.96 | $3.96 | $3.76 | 14,663 | |
| $3.96 | +0.13 | +3.4% | $4.01 | $4.01 | $3.75 | 13,500 | |
| $3.83 | +0.07 | +1.9% | $3.79 | $3.885 | $3.79 | 8,276 | |
| $3.76 | -0.15 | -3.8% | $4.04 | $4.08 | $3.715 | 33,601 | |
| $3.91 | -0.17 | -4.2% | $4.01 | $4.155 | $3.84 | 22,562 | |
| $4.08 | -0.19 | -4.4% | $3.79 | $4.70 | $3.65 | 547,184 | |
| $4.27 | +0.105 | +2.5% | $4.13 | $4.40 | $4.13 | 16,826 | |
| $4.165 | +0.145 | +3.6% | $4.05 | $4.42 | $4.03 | 19,816 | |
| $4.02 | 0.00 | 0.0% | $3.925 | $4.05 | $3.90 | 11,381 | |
| $4.02 | -0.17 | -4.1% | $4.20 | $4.23 | $3.97 | 15,648 | |
| $4.19 | -0.12 | -2.8% | $4.31 | $4.34 | $4.13 | 18,298 | |
| $4.31 | -0.22 | -4.9% | $4.50 | $4.83 | $4.21 | 47,568 | |
| $4.53 | -0.01 | -0.2% | $4.494 | $4.728 | $4.40 | 14,673 | |
| $4.54 | +0.19 | +4.4% | $4.42 | $4.804 | $4.40 | 23,297 | |
| $4.35 | -0.22 | -4.8% | $4.57 | $4.65 | $4.26 | 29,517 | |
| $4.57 | 0.00 | 0.0% | $4.68 | $4.75 | $4.54 | 9,638 | |
| $4.57 | -0.165 | -3.5% | $4.76 | $4.99 | $4.56 | 26,720 | |
| $4.735 | -0.155 | -3.2% | $4.77 | $4.93 | $4.56 | 41,081 | |
| $4.89 | -0.035 | -0.7% | $4.82 | $4.932 | $4.75 | 15,092 | |
| $4.925 | -0.11 | -2.2% | $5.00 | $5.51 | $4.894 | 81,862 | |
| $5.035 | +0.175 | +3.6% | $4.86 | $5.15 | $4.75 | 22,643 | |
| $4.86 | +0.34 | +7.5% | $4.53 | $5.198 | $4.53 | 71,125 | |
| $4.52 | +0.09 | +2.0% | $4.34 | $4.76 | $4.34 | 27,832 | |
| $4.43 | +0.18 | +4.2% | $4.29 | $4.501 | $4.28 | 27,181 | |
| $4.25 | +0.19 | +4.7% | $4.05 | $4.62 | $4.05 | 48,947 | |
| $4.06 | -0.21 | -4.9% | $4.24 | $4.40 | $4.02 | 27,709 | |
| $4.27 | -0.03 | -0.7% | $4.40 | $4.50 | $4.18 | 26,009 | |
| $4.30 | -0.12 | -2.7% | $4.39 | $4.54 | $4.20 | 36,408 | |
| $4.42 | +0.03 | +0.7% | $4.52 | $4.633 | $4.38 | 15,183 | |
| $4.39 | -0.14 | -3.1% | $4.52 | $4.72 | $4.23 | 42,866 | |
| $4.53 | +0.32 | +7.6% | $4.24 | $4.748 | $4.21 | 69,784 | |
| $4.21 | -0.15 | -3.4% | $4.375 | $4.488 | $4.12 | 25,446 | |
| $4.36 | +0.26 | +6.3% | $4.00 | $4.565 | $4.00 | 36,457 | |
| $4.10 | -0.32 | -7.2% | $4.61 | $4.678 | $3.81 | 86,686 | |
| $4.42 | +0.97 | +28.1% | $3.47 | $4.42 | $3.391 | 103,692 | |
| $3.45 | +0.17 | +5.2% | $3.36 | $3.49 | $3.28 | 41,872 | |
| $3.28 | -0.19 | -5.5% | $3.43 | $3.50 | $3.28 | 26,737 | |
| $3.47 | +0.06 | +1.8% | $3.45 | $3.55 | $3.358 | 35,765 |
- Ticker
- BOATS:ERNA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment
Latest deck · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 19 slides
Latest news
Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment
Oct 22, 2026
Closed $2.08 (-1.7%) on Oct 22, 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Oct 12, 2026
Closed $2.21 (0.0%) on Oct 13, 2026
Ernexa Therapeutics’ ERNA-101 Selected for Flash Talk Presentation at Nature Conferences’ Next-Generation Cancer Therapeutics Meeting Co-Hosted by MD Anderson Cancer Center
Oct 6, 2026
Closed $2.24 (-17.2%) on Oct 6, 2026
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
Oct 1, 2026
Closed $2.96 (-7.5%) on Oct 1, 2026
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
Sep 30, 2026
Closed $3.20 (+1.3%) on Sep 30, 2026
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
Sep 29, 2026
Closed $3.16 (-8.9%) on Sep 29, 2026
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
Sep 17, 2026
Closed $3.76 (-3.8%) on Sep 17, 2026
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 14, 2026
Closed $4.27 (+2.5%) on Sep 14, 2026
Initial Statement of Beneficial Ownership (Form 3)
Aug 28, 2026
Closed $4.57 (-3.5%) on Aug 28, 2026
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
Aug 27, 2026
Closed $4.74 (-3.2%) on Aug 27, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 19 slides · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 19 slides · Oct 15, 2026
Investor Presentation (September 2026)
Investor deck · 17 slides · September 2026
Investor Presentation (July 2026)
Investor deck · 24 slides · Jul 2, 2026
Ernexa Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 72 in all · newest Oct 22, 2026 · oldest 2022
- Decks
- 12 decks · latest Oct 15, 2026
Where Ernexa Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ERNA · Home listing | NASDAQ | United States | USD |
| BOATS:ERNA · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Ernexa Therapeutics Inc.